Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-08
1995-05-30
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549 16, C07D32708, A61K 3139
Patent
active
054201560
ABSTRACT:
1-Ethylphenoxathiin 10,10-dioxide (I) ##STR1## inhibits monoamine oxidase-A and is useful in the treatment of disorders such as depression.
REFERENCES:
patent: 2997422 (1961-08-01), Tedeschi et al.
patent: 3981887 (1976-09-01), Gante et al.
patent: 4012517 (1977-03-01), Follenfant
patent: 4091108 (1978-05-01), Batchelor et al.
patent: 4976771 (1990-12-01), Anthony et al.
J. March, "Advanced Organic Chemistry", 2nd. edition, pp. 399-400, 1119-1120, McGraw-Hill Book Co., New York, (1977).
F. Carey, et al., "Advanced Organic Chemistry", 2nd. edition, pp. 199-202, (1983).
Abstract No. 89-179824/25, Nippon Oils & Fats KK, N10F, Dec. 15, 1987.
Harfenist, et al., J. Med. Chem. vol. 34, No. 9, pp. 2931-2933, (Sep. 1991).
Cooper Barrett R.
Harfenist Morton
McGee Daniel P. C.
White Helen L.
Brown Donald
Burroughs Wellcome Co.
Nielsen Lawrence A.
Raymond Richard L.
LandOfFree
Pharmacologically active compound and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmacologically active compound and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacologically active compound and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-362205